Health action with informed and engaged societies
After nearly 28 years, The Communication Initiative (The CI) Global is entering a new chapter. Following a period of transition, the global website has been transferred to the University of the Witwatersrand (Wits) in South Africa, where it will be administered by the Social and Behaviour Change Communication Division. Wits' commitment to social change and justice makes it a trusted steward for The CI's legacy and future.
 
Co-founder Victoria Martin is pleased to see this work continue under Wits' leadership. Victoria knows that co-founder Warren Feek (1953–2024) would have felt deep pride in The CI Global's Africa-led direction.
 
We honour the team and partners who sustained The CI for decades. Meanwhile, La Iniciativa de Comunicación (CILA) continues independently at cila.comminitcila.com and is linked with The CI Global site.
Time to read
less than
1 minute
Read so far

PLoS Clinical Trials Journal

0 comments
SummaryText
Launched in May 2006, this is an international, peer-reviewed, open-access journal published online by the Public Library of Science (PLoS). The journal welcomes articles from around the globe reporting results of randomised trials in all fields of healthcare, irrespective of their outcome.

The journal is committed to a transparent trials reporting system of all randomised trials that are ethically and scientifically sound, registered, and reported accurately. By considering all such trials for publication irrespective of the outcome of the results, the journal aims to increase the accuracy and completeness of the evidence available for clinical decision-making by practitioners, policymakers, and patients. All trials considered for publication are rigorously peer-reviewed by expert statisticians and clinicians.

As an online journal, PLoS Clinical Trials aims to take advantage of the unlimited space and interactivity the web provides. Each published trial is linked to its corresponding entry in a public registry and supplementary data, such as original trial protocols, are linked to each report enabling readers to evaluate the trial more thoroughly. A short commentary on each paper summarises for a general audience how the trial results add to the evidence.

Open access means that the full contents of PLoS Clinical Trials are available to anyone to read and re-use for free, not only to researchers and practitioners but also to patients and trial participants.
Source

Malaria in the News, May 12-19 2006, from the Roll Back Malaria Partnership.